<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>177(3)</volume><submitter>Giannakeas V</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Women with ER-positive breast cancer may recur as late as 20 years post-diagnosis. The reason for this delayed recurrence is unknown. We studied survival patterns, including time-to-death in 123,705 women with stage I to III invasive breast cancer, enrolled in the SEER database. Among these 76.8% were ER-positive and 23.2% were ER-negative.&lt;h4>Methods&lt;/h4>We divided the cohort into ten classes with varying risks of death from breast cancer. The 20-year mortality for women in the highest risk decile 10 was 69% versus 5% for women in the lowest decile 1. The difference in the time-to-death by decile could be explained by a variable α which represents the annual rate of reactivation from tumour dormancy.&lt;h4>Results&lt;/h4>The duration of tumour dormancy was much longer, on ave</pubmed_abstract><journal>Breast cancer research and treatment</journal><pagination>691-703</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6745044</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumour dormancy.</pubmed_title><pmcid>PMC6745044</pmcid><pubmed_authors>Narod SA</pubmed_authors><pubmed_authors>Giannakeas V</pubmed_authors></additional><is_claimable>false</is_claimable><name>A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumour dormancy.</name><description>&lt;h4>Background&lt;/h4>Women with ER-positive breast cancer may recur as late as 20 years post-diagnosis. The reason for this delayed recurrence is unknown. We studied survival patterns, including time-to-death in 123,705 women with stage I to III invasive breast cancer, enrolled in the SEER database. Among these 76.8% were ER-positive and 23.2% were ER-negative.&lt;h4>Methods&lt;/h4>We divided the cohort into ten classes with varying risks of death from breast cancer. The 20-year mortality for women in the highest risk decile 10 was 69% versus 5% for women in the lowest decile 1. The difference in the time-to-death by decile could be explained by a variable α which represents the annual rate of reactivation from tumour dormancy.&lt;h4>Results&lt;/h4>The duration of tumour dormancy was much longer, on ave</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Oct</publication><modification>2025-04-22T06:13:17.586Z</modification><creation>2019-10-11T07:05:32Z</creation></dates><accession>S-EPMC6745044</accession><cross_references><pubmed>31264063</pubmed><doi>10.1007/s10549-019-05334-5</doi></cross_references></HashMap>